Ionis Pharma CEO: Nusinersen an 'enormous commercial opportunity'
August 01, 2016 at 18:51 PM EDT
Jim Cramer spoke with the CEO of Ionis Pharmaceuticals, which skyrocketed on Monday following positive data for its spinal muscular atrophy drug.
